

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ensheathment of neurons (GO:0007272) | 6.88590775 |
| 2 | axon ensheathment (GO:0008366) | 6.88590775 |
| 3 | myelination (GO:0042552) | 6.86516861 |
| 4 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.54122834 |
| 5 | * fatty acid elongation (GO:0030497) | 6.38170517 |
| 6 | thrombin receptor signaling pathway (GO:0070493) | 6.06118164 |
| 7 | cholesterol biosynthetic process (GO:0006695) | 5.72715173 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.53823495 |
| 9 | myelin maintenance (GO:0043217) | 5.12598918 |
| 10 | sterol biosynthetic process (GO:0016126) | 5.11711305 |
| 11 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.10461992 |
| 12 | negative regulation of neurotransmitter transport (GO:0051589) | 4.87783926 |
| 13 | amyloid precursor protein metabolic process (GO:0042982) | 4.80909269 |
| 14 | response to methylmercury (GO:0051597) | 4.71982778 |
| 15 | glycerophospholipid catabolic process (GO:0046475) | 4.70499026 |
| 16 | isoprenoid biosynthetic process (GO:0008299) | 4.48611524 |
| 17 | regulation of collateral sprouting (GO:0048670) | 4.46481709 |
| 18 | negative regulation of protein localization to cell surface (GO:2000009) | 4.35174464 |
| 19 | eye photoreceptor cell differentiation (GO:0001754) | 4.32519710 |
| 20 | photoreceptor cell differentiation (GO:0046530) | 4.32519710 |
| 21 | establishment of mitochondrion localization (GO:0051654) | 4.30880782 |
| 22 | L-amino acid import (GO:0043092) | 4.27921965 |
| 23 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.27055031 |
| 24 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.06971187 |
| 25 | regulation of platelet activation (GO:0010543) | 4.06164558 |
| 26 | oligodendrocyte differentiation (GO:0048709) | 4.02473013 |
| 27 | regulation of integrin activation (GO:0033623) | 4.01688090 |
| 28 | establishment of skin barrier (GO:0061436) | 4.01061909 |
| 29 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.98155514 |
| 30 | import into cell (GO:0098657) | 3.89134994 |
| 31 | adenosine receptor signaling pathway (GO:0001973) | 3.87748735 |
| 32 | lipoxygenase pathway (GO:0019372) | 3.84160262 |
| 33 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.83700460 |
| 34 | creatine metabolic process (GO:0006600) | 3.82938959 |
| 35 | regulation of platelet aggregation (GO:0090330) | 3.81191731 |
| 36 | response to redox state (GO:0051775) | 3.80632288 |
| 37 | substantia nigra development (GO:0021762) | 3.78475039 |
| 38 | response to lipoprotein particle (GO:0055094) | 3.75269063 |
| 39 | magnesium ion transport (GO:0015693) | 3.74374308 |
| 40 | asymmetric protein localization (GO:0008105) | 3.73651977 |
| 41 | apical protein localization (GO:0045176) | 3.70553079 |
| 42 | neutrophil activation (GO:0042119) | 3.67629342 |
| 43 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.66147341 |
| 44 | granulocyte activation (GO:0036230) | 3.63941074 |
| 45 | presynaptic membrane organization (GO:0097090) | 3.63365923 |
| 46 | astrocyte development (GO:0014002) | 3.58929654 |
| 47 | negative regulation of lipid storage (GO:0010888) | 3.54359110 |
| 48 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.53811942 |
| 49 | regulation of water loss via skin (GO:0033561) | 3.53775910 |
| 50 | negative regulation of norepinephrine secretion (GO:0010700) | 3.51588385 |
| 51 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.49138812 |
| 52 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.48653038 |
| 53 | protein palmitoylation (GO:0018345) | 3.45546965 |
| 54 | GPI anchor biosynthetic process (GO:0006506) | 3.43343028 |
| 55 | amyloid precursor protein catabolic process (GO:0042987) | 3.39338073 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.37136953 |
| 57 | keratinization (GO:0031424) | 3.37011053 |
| 58 | negative regulation of platelet activation (GO:0010544) | 3.36471993 |
| 59 | angiogenesis involved in wound healing (GO:0060055) | 3.36093430 |
| 60 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.32077087 |
| 61 | * long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.31926398 |
| 62 | regulation of lipoprotein metabolic process (GO:0050746) | 3.31907037 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.31556714 |
| 64 | GPI anchor metabolic process (GO:0006505) | 3.30829606 |
| 65 | regulation of chronic inflammatory response (GO:0002676) | 3.30750983 |
| 66 | nucleotide transmembrane transport (GO:1901679) | 3.28991576 |
| 67 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.28333186 |
| 68 | blood coagulation, intrinsic pathway (GO:0007597) | 3.27915423 |
| 69 | positive regulation of mast cell activation (GO:0033005) | 3.27884782 |
| 70 | virion attachment to host cell (GO:0019062) | 3.27744510 |
| 71 | adhesion of symbiont to host cell (GO:0044650) | 3.27744510 |
| 72 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.26623473 |
| 73 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.26564465 |
| 74 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.24568782 |
| 75 | axon development (GO:0061564) | 3.23734225 |
| 76 | myelination in peripheral nervous system (GO:0022011) | 3.23451758 |
| 77 | peripheral nervous system axon ensheathment (GO:0032292) | 3.23451758 |
| 78 | platelet aggregation (GO:0070527) | 3.19527390 |
| 79 | amino acid import (GO:0043090) | 3.17587955 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.15066341 |
| 81 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.14656990 |
| 82 | * long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.14549358 |
| 83 | limb bud formation (GO:0060174) | 3.13417117 |
| 84 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.12909661 |
| 85 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.11519972 |
| 86 | protein neddylation (GO:0045116) | 3.11474810 |
| 87 | membrane tubulation (GO:0097320) | 3.07502921 |
| 88 | regulation of vitamin metabolic process (GO:0030656) | 3.06505203 |
| 89 | regulation of memory T cell differentiation (GO:0043380) | 3.03617912 |
| 90 | cyclooxygenase pathway (GO:0019371) | 3.01447709 |
| 91 | glycosylceramide metabolic process (GO:0006677) | 3.01352623 |
| 92 | peripheral nervous system development (GO:0007422) | 2.99953606 |
| 93 | polyamine biosynthetic process (GO:0006596) | 2.98620357 |
| 94 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.98348784 |
| 95 | regulation of immunoglobulin secretion (GO:0051023) | 2.97934913 |
| 96 | negative regulation of interleukin-17 production (GO:0032700) | 2.96088433 |
| 97 | negative regulation of axonogenesis (GO:0050771) | 2.96041905 |
| 98 | beta-amyloid metabolic process (GO:0050435) | 2.92987350 |
| 99 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.92903214 |
| 100 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.92903214 |
| 101 | positive regulation of immune response to tumor cell (GO:0002839) | 2.90942409 |
| 102 | regulation of immune response to tumor cell (GO:0002837) | 2.90942409 |
| 103 | regulation of response to tumor cell (GO:0002834) | 2.90942409 |
| 104 | positive regulation of response to tumor cell (GO:0002836) | 2.90942409 |
| 105 | positive regulation of type 2 immune response (GO:0002830) | 2.89361262 |
| 106 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.88154227 |
| 107 | neuron remodeling (GO:0016322) | 2.85374999 |
| 108 | organ growth (GO:0035265) | 2.83871158 |
| 109 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.83653396 |
| 110 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.83117900 |
| 111 | sphingosine metabolic process (GO:0006670) | 2.82206724 |
| 112 | * fatty-acyl-CoA metabolic process (GO:0035337) | 2.82075180 |
| 113 | cranial nerve development (GO:0021545) | 2.81625318 |
| 114 | regulation of norepinephrine secretion (GO:0014061) | 2.80602782 |
| 115 | positive regulation of actin filament depolymerization (GO:0030836) | 2.80404052 |
| 116 | histamine transport (GO:0051608) | 2.80240773 |
| 117 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.80059734 |
| 118 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.77993278 |
| 119 | adult walking behavior (GO:0007628) | 2.77631412 |
| 120 | diol metabolic process (GO:0034311) | 2.77308506 |
| 121 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.75299684 |
| 122 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.74912189 |
| 123 | linoleic acid metabolic process (GO:0043651) | 2.74154966 |
| 124 | amine catabolic process (GO:0009310) | 2.73411688 |
| 125 | cellular biogenic amine catabolic process (GO:0042402) | 2.73411688 |
| 126 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.73207039 |
| 127 | peptidyl-cysteine modification (GO:0018198) | 2.73163227 |
| 128 | regulation of podosome assembly (GO:0071801) | 2.73094756 |
| 129 | positive regulation of heat generation (GO:0031652) | 2.72917137 |
| 130 | positive regulation of action potential (GO:0045760) | 2.71752962 |
| 131 | endothelium development (GO:0003158) | 2.70852231 |
| 132 | positive regulation of macrophage differentiation (GO:0045651) | 2.70508583 |
| 133 | enteric nervous system development (GO:0048484) | 2.69893334 |
| 134 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67818310 |
| 135 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.66054310 |
| 136 | megakaryocyte development (GO:0035855) | 2.65828796 |
| 137 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.65055904 |
| 138 | regulation of regulatory T cell differentiation (GO:0045589) | 2.64929220 |
| 139 | natural killer cell activation involved in immune response (GO:0002323) | 2.64422412 |
| 140 | cellular response to epinephrine stimulus (GO:0071872) | 2.63359836 |
| 141 | positive regulation of blood coagulation (GO:0030194) | 2.63272821 |
| 142 | positive regulation of hemostasis (GO:1900048) | 2.63272821 |
| 143 | * fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.62703492 |
| 144 | nerve growth factor signaling pathway (GO:0038180) | 2.62572099 |
| 145 | purinergic receptor signaling pathway (GO:0035587) | 2.62393304 |
| 146 | transmission of nerve impulse (GO:0019226) | 2.62125759 |
| 147 | neuronal action potential propagation (GO:0019227) | 2.61978973 |
| 148 | peptide catabolic process (GO:0043171) | 2.61581225 |
| 149 | negative regulation of axon extension (GO:0030517) | 2.61033620 |
| 150 | positive regulation of interleukin-6 production (GO:0032755) | 2.60940490 |
| 151 | platelet degranulation (GO:0002576) | 2.59912044 |
| 152 | alcohol biosynthetic process (GO:0046165) | 2.59593189 |
| 153 | platelet activation (GO:0030168) | 2.57331127 |
| 154 | neural nucleus development (GO:0048857) | 2.55353346 |
| 155 | positive regulation of coagulation (GO:0050820) | 2.55228139 |
| 156 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.55124902 |
| 157 | regulation of fever generation (GO:0031620) | 2.54769283 |
| 158 | negative regulation of macroautophagy (GO:0016242) | 2.54521233 |
| 159 | phosphatidylserine metabolic process (GO:0006658) | 2.52720080 |
| 160 | positive regulation of glial cell differentiation (GO:0045687) | 2.51568593 |
| 161 | neurotransmitter uptake (GO:0001504) | 2.51082487 |
| 162 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.50986894 |
| 163 | sphingoid metabolic process (GO:0046519) | 2.50800033 |
| 164 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.50678166 |
| 165 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.50501973 |
| 166 | neuron cell-cell adhesion (GO:0007158) | 2.48527969 |
| 167 | ceramide biosynthetic process (GO:0046513) | 2.47907480 |
| 168 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.46523872 |
| 169 | neuronal ion channel clustering (GO:0045161) | 2.46205565 |
| 170 | glial cell development (GO:0021782) | 2.46130369 |
| 171 | glutathione biosynthetic process (GO:0006750) | 2.44831337 |
| 172 | negative regulation of JUN kinase activity (GO:0043508) | 2.44481109 |
| 173 | regulation of somitogenesis (GO:0014807) | 2.44073705 |
| 174 | detection of temperature stimulus (GO:0016048) | 2.43792672 |
| 175 | leukocyte degranulation (GO:0043299) | 2.43517217 |
| 176 | response to epinephrine (GO:0071871) | 2.43469657 |
| 177 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.43434373 |
| 178 | positive regulation of B cell mediated immunity (GO:0002714) | 2.42985653 |
| 179 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.42985653 |
| 180 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.42445266 |
| 181 | positive regulation of alcohol biosynthetic process (GO:1902932) | 2.42218742 |
| 182 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.42181839 |
| 183 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.42181839 |
| 184 | membrane lipid biosynthetic process (GO:0046467) | 2.40665539 |
| 185 | regulation of hemostasis (GO:1900046) | 2.40323772 |
| 186 | regulation of blood coagulation (GO:0030193) | 2.40323772 |
| 187 | glycolipid biosynthetic process (GO:0009247) | 2.39890707 |
| 188 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.39472642 |
| 189 | iron coordination entity transport (GO:1901678) | 2.39405325 |
| 190 | regulation of interleukin-17 production (GO:0032660) | 2.38599983 |
| 191 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.38269535 |
| 192 | dendritic cell chemotaxis (GO:0002407) | 2.37225537 |
| 193 | axon ensheathment in central nervous system (GO:0032291) | 11.4608116 |
| 194 | central nervous system myelination (GO:0022010) | 11.4608116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.21569535 |
| 2 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.18120077 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.05684284 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.03965241 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.00729656 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.00336229 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.94395662 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.93631984 |
| 9 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.82850221 |
| 10 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.67954413 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.58034140 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.48339162 |
| 13 | GATA1_19941826_ChIP-Seq_K562_Human | 2.44994460 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.43237911 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.33476634 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.22448193 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.20552094 |
| 18 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.18786697 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.16270117 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.14221653 |
| 21 | GATA2_19941826_ChIP-Seq_K562_Human | 2.12786023 |
| 22 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.12536278 |
| 23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.08889867 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.08212958 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.07169778 |
| 26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.07024935 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.06154809 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04634452 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01532868 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.01114189 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98579448 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.98250799 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98201116 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.95450230 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94788426 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91758718 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.84330337 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.79391770 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77920074 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77241312 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77155930 |
| 42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.77154300 |
| 43 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.75454176 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.74530657 |
| 45 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74492731 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.73850118 |
| 47 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.73586200 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70509753 |
| 49 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70509753 |
| 50 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.69725490 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68464835 |
| 52 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.68435050 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68325369 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65289452 |
| 55 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.65215504 |
| 56 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63489098 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.63052547 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59385381 |
| 59 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58771811 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.56704696 |
| 61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.56145919 |
| 62 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.55847742 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.55302296 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54781885 |
| 65 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.53232857 |
| 66 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.52369358 |
| 67 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.52033573 |
| 68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49802053 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48721663 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48635959 |
| 71 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48387043 |
| 72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43682451 |
| 73 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43627245 |
| 74 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.41653924 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41367602 |
| 76 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.39849325 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39721107 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38847612 |
| 79 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37929938 |
| 80 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37181271 |
| 81 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36095646 |
| 82 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35548504 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.35376476 |
| 84 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.34893127 |
| 85 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32459683 |
| 86 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.26524745 |
| 87 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25674756 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24063813 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24063813 |
| 90 | FUS_26573619_Chip-Seq_HEK293_Human | 1.23449384 |
| 91 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22930057 |
| 92 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22650768 |
| 93 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.22289142 |
| 94 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21873225 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20247247 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20055013 |
| 97 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19447817 |
| 98 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18860703 |
| 99 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18657635 |
| 100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18657635 |
| 101 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.18556034 |
| 102 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18179960 |
| 103 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.17722601 |
| 104 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16922900 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15934755 |
| 106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15432296 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15377432 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14344756 |
| 109 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13806159 |
| 110 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13742592 |
| 111 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12704943 |
| 112 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12550148 |
| 113 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12396674 |
| 114 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12149250 |
| 115 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12106271 |
| 116 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.11727102 |
| 117 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11431126 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08381424 |
| 119 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06927314 |
| 120 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06256230 |
| 121 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06190580 |
| 122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04820399 |
| 123 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04798785 |
| 124 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04585914 |
| 125 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03864768 |
| 126 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03171468 |
| 127 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03008710 |
| 128 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02965771 |
| 129 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02582059 |
| 130 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01916101 |
| 131 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.01845827 |
| 132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.01701500 |
| 133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01432566 |
| 134 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00954093 |
| 135 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00233653 |
| 136 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00093451 |
| 137 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99653073 |
| 138 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99243783 |
| 139 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98267785 |
| 140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98056907 |
| 141 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.97607804 |
| 142 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97530446 |
| 143 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97518148 |
| 144 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97495777 |
| 145 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.97493642 |
| 146 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97342295 |
| 147 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97034604 |
| 148 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96676238 |
| 149 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96153195 |
| 150 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96038247 |
| 151 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96038247 |
| 152 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95609350 |
| 153 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.95437482 |
| 154 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95329028 |
| 155 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.95021796 |
| 156 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94806907 |
| 157 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94772433 |
| 158 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.94599434 |
| 159 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93853898 |
| 160 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93189803 |
| 161 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93118631 |
| 162 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92503161 |
| 163 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92423925 |
| 164 | TBL1_22424771_ChIP-Seq_293T_Human | 0.91608614 |
| 165 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91361065 |
| 166 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91247019 |
| 167 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.91017081 |
| 168 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90923075 |
| 169 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90831587 |
| 170 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89973108 |
| 171 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88558054 |
| 172 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88234373 |
| 173 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87934845 |
| 174 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87832054 |
| 175 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.87774884 |
| 176 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85820247 |
| 177 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84929758 |
| 178 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84440578 |
| 179 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84362622 |
| 180 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.84100943 |
| 181 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83728165 |
| 182 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81064825 |
| 183 | AR_25329375_ChIP-Seq_VCAP_Human | 0.79460163 |
| 184 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76296084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 6.03423544 |
| 2 | MP0000920_abnormal_myelination | 5.48367753 |
| 3 | MP0008004_abnormal_stomach_pH | 4.66716497 |
| 4 | MP0003303_peritoneal_inflammation | 3.84939771 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.62421445 |
| 6 | MP0004510_myositis | 3.48344419 |
| 7 | MP0003724_increased_susceptibility_to | 3.43581256 |
| 8 | MP0004270_analgesia | 3.21185682 |
| 9 | MP0003880_abnormal_central_pattern | 3.19756039 |
| 10 | MP0003690_abnormal_glial_cell | 2.98536324 |
| 11 | MP0004742_abnormal_vestibular_system | 2.85186882 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 2.67440213 |
| 13 | MP0004947_skin_inflammation | 2.66970074 |
| 14 | MP0003329_amyloid_beta_deposits | 2.65827409 |
| 15 | MP0003136_yellow_coat_color | 2.61969980 |
| 16 | MP0004885_abnormal_endolymph | 2.58008485 |
| 17 | MP0005409_darkened_coat_color | 2.55889369 |
| 18 | MP0005171_absent_coat_pigmentation | 2.52087253 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.50690890 |
| 20 | MP0001905_abnormal_dopamine_level | 2.47374974 |
| 21 | MP0001485_abnormal_pinna_reflex | 2.46204189 |
| 22 | MP0001529_abnormal_vocalization | 2.45559421 |
| 23 | MP0010678_abnormal_skin_adnexa | 2.41477472 |
| 24 | MP0000465_gastrointestinal_hemorrhage | 2.37813046 |
| 25 | MP0002272_abnormal_nervous_system | 2.32858691 |
| 26 | MP0000383_abnormal_hair_follicle | 2.29196266 |
| 27 | MP0003453_abnormal_keratinocyte_physiol | 2.21304281 |
| 28 | MP0003634_abnormal_glial_cell | 2.20145079 |
| 29 | MP0001486_abnormal_startle_reflex | 2.18218396 |
| 30 | MP0004381_abnormal_hair_follicle | 2.02952929 |
| 31 | MP0000778_abnormal_nervous_system | 2.02242539 |
| 32 | MP0005451_abnormal_body_composition | 1.99336178 |
| 33 | MP0004142_abnormal_muscle_tone | 1.97700299 |
| 34 | MP0000462_abnormal_digestive_system | 1.97423432 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.97135622 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.96644577 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.93104674 |
| 38 | MP0000343_altered_response_to | 1.91059388 |
| 39 | MP0003632_abnormal_nervous_system | 1.86264068 |
| 40 | MP0002229_neurodegeneration | 1.81694721 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.79770849 |
| 42 | MP0002064_seizures | 1.79266814 |
| 43 | MP0005410_abnormal_fertilization | 1.78996744 |
| 44 | MP0002734_abnormal_mechanical_nocicepti | 1.74178794 |
| 45 | MP0004043_abnormal_pH_regulation | 1.72245580 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.71553543 |
| 47 | MP0005501_abnormal_skin_physiology | 1.66977475 |
| 48 | MP0005423_abnormal_somatic_nervous | 1.65763861 |
| 49 | MP0009785_altered_susceptibility_to | 1.64610789 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.62455639 |
| 51 | MP0009764_decreased_sensitivity_to | 1.61868139 |
| 52 | MP0003195_calcinosis | 1.61119001 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.59418339 |
| 54 | MP0000230_abnormal_systemic_arterial | 1.58544537 |
| 55 | MP0003436_decreased_susceptibility_to | 1.57697567 |
| 56 | MP0000566_synostosis | 1.56812436 |
| 57 | MP0005671_abnormal_response_to | 1.55695704 |
| 58 | MP0008260_abnormal_autophagy | 1.49303787 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.48829647 |
| 60 | MP0006082_CNS_inflammation | 1.44671904 |
| 61 | MP0003075_altered_response_to | 1.44191058 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.39971099 |
| 63 | MP0009046_muscle_twitch | 1.39411012 |
| 64 | MP0003631_nervous_system_phenotype | 1.39163021 |
| 65 | MP0004147_increased_porphyrin_level | 1.38424283 |
| 66 | MP0000647_abnormal_sebaceous_gland | 1.38022864 |
| 67 | MP0001346_abnormal_lacrimal_gland | 1.36486976 |
| 68 | MP0004134_abnormal_chest_morphology | 1.35653084 |
| 69 | MP0003638_abnormal_response/metabolism_ | 1.35465356 |
| 70 | MP0005387_immune_system_phenotype | 1.35054608 |
| 71 | MP0001790_abnormal_immune_system | 1.35054608 |
| 72 | MP0005551_abnormal_eye_electrophysiolog | 1.33449391 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.30887627 |
| 74 | MP0001963_abnormal_hearing_physiology | 1.30272460 |
| 75 | MP0009745_abnormal_behavioral_response | 1.27465839 |
| 76 | MP0001970_abnormal_pain_threshold | 1.27286457 |
| 77 | MP0002723_abnormal_immune_serum | 1.26662879 |
| 78 | MP0000604_amyloidosis | 1.26143439 |
| 79 | MP0000955_abnormal_spinal_cord | 1.24950488 |
| 80 | MP0001845_abnormal_inflammatory_respons | 1.24603676 |
| 81 | MP0002882_abnormal_neuron_morphology | 1.24363155 |
| 82 | MP0008872_abnormal_physiological_respon | 1.21994897 |
| 83 | MP0002452_abnormal_antigen_presenting | 1.21752792 |
| 84 | MP0001440_abnormal_grooming_behavior | 1.20777162 |
| 85 | MP0002735_abnormal_chemical_nociception | 1.20565345 |
| 86 | MP0003879_abnormal_hair_cell | 1.20171159 |
| 87 | MP0004859_abnormal_synaptic_plasticity | 1.19818317 |
| 88 | MP0005025_abnormal_response_to | 1.18002685 |
| 89 | MP0000762_abnormal_tongue_morphology | 1.17811005 |
| 90 | MP0003635_abnormal_synaptic_transmissio | 1.17187717 |
| 91 | MP0000579_abnormal_nail_morphology | 1.15855651 |
| 92 | MP0003633_abnormal_nervous_system | 1.15627670 |
| 93 | MP0001216_abnormal_epidermal_layer | 1.14799146 |
| 94 | MP0009763_increased_sensitivity_to | 1.14569810 |
| 95 | MP0002419_abnormal_innate_immunity | 1.14371363 |
| 96 | MP0000372_irregular_coat_pigmentation | 1.13611485 |
| 97 | MP0002752_abnormal_somatic_nervous | 1.13365114 |
| 98 | MP0001800_abnormal_humoral_immune | 1.13092274 |
| 99 | MP0001986_abnormal_taste_sensitivity | 1.12809676 |
| 100 | MP0000858_altered_metastatic_potential | 1.12758312 |
| 101 | MP0001661_extended_life_span | 1.12697172 |
| 102 | MP0005365_abnormal_bile_salt | 1.10395522 |
| 103 | MP0005408_hypopigmentation | 1.10018064 |
| 104 | MP0010329_abnormal_lipoprotein_level | 1.09980200 |
| 105 | MP0005166_decreased_susceptibility_to | 1.09871585 |
| 106 | MP0001663_abnormal_digestive_system | 1.09763898 |
| 107 | MP0002067_abnormal_sensory_capabilities | 1.09156037 |
| 108 | MP0003183_abnormal_peptide_metabolism | 1.08822205 |
| 109 | MP0002066_abnormal_motor_capabilities/c | 1.07482044 |
| 110 | MP0002733_abnormal_thermal_nociception | 1.07319035 |
| 111 | MP0001851_eye_inflammation | 1.07234022 |
| 112 | MP0009840_abnormal_foam_cell | 1.06339376 |
| 113 | MP0002572_abnormal_emotion/affect_behav | 1.05806841 |
| 114 | MP0003938_abnormal_ear_development | 1.05026198 |
| 115 | MP0001299_abnormal_eye_distance/ | 1.04388646 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 1.03888706 |
| 117 | MP0008569_lethality_at_weaning | 1.03446921 |
| 118 | MP0003937_abnormal_limbs/digits/tail_de | 1.01629284 |
| 119 | MP0001765_abnormal_ion_homeostasis | 1.01364562 |
| 120 | MP0005165_increased_susceptibility_to | 1.00640405 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 1.00277615 |
| 122 | MP0000249_abnormal_blood_vessel | 0.99651432 |
| 123 | MP0005023_abnormal_wound_healing | 0.99587492 |
| 124 | MP0005647_abnormal_sex_gland | 0.99518659 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.98696890 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.98493982 |
| 127 | MP0000747_muscle_weakness | 0.97767873 |
| 128 | MP0001968_abnormal_touch/_nociception | 0.96837640 |
| 129 | MP0002295_abnormal_pulmonary_circulatio | 0.96211936 |
| 130 | MP0004084_abnormal_cardiac_muscle | 0.95956425 |
| 131 | MP0001501_abnormal_sleep_pattern | 0.95405744 |
| 132 | MP0002998_abnormal_bone_remodeling | 0.95125966 |
| 133 | MP0008874_decreased_physiological_sensi | 0.95000787 |
| 134 | MP0000467_abnormal_esophagus_morphology | 0.94816797 |
| 135 | MP0003448_altered_tumor_morphology | 0.94369212 |
| 136 | MP0005535_abnormal_body_temperature | 0.94095189 |
| 137 | MP0005195_abnormal_posterior_eye | 0.94068000 |
| 138 | MP0005386_behavior/neurological_phenoty | 0.93907485 |
| 139 | MP0004924_abnormal_behavior | 0.93907485 |
| 140 | MP0005310_abnormal_salivary_gland | 0.93164093 |
| 141 | MP0000015_abnormal_ear_pigmentation | 0.93064098 |
| 142 | MP0005397_hematopoietic_system_phenotyp | 0.92551177 |
| 143 | MP0001545_abnormal_hematopoietic_system | 0.92551177 |
| 144 | MP0005623_abnormal_meninges_morphology | 0.92342206 |
| 145 | MP0000026_abnormal_inner_ear | 0.91944858 |
| 146 | MP0002736_abnormal_nociception_after | 0.91896595 |
| 147 | MP0005666_abnormal_adipose_tissue | 0.90463457 |
| 148 | MP0005083_abnormal_biliary_tract | 0.89213553 |
| 149 | MP0006054_spinal_hemorrhage | 0.89181034 |
| 150 | MP0002063_abnormal_learning/memory/cond | 0.88926097 |
| 151 | MP0002796_impaired_skin_barrier | 0.88888617 |
| 152 | MP0001819_abnormal_immune_cell | 0.85870266 |
| 153 | MP0004484_altered_response_of | 0.85393908 |
| 154 | MP0002420_abnormal_adaptive_immunity | 0.84013912 |
| 155 | MP0002118_abnormal_lipid_homeostasis | 0.83277095 |
| 156 | MP0008775_abnormal_heart_ventricle | 0.82133896 |
| 157 | MP0009765_abnormal_xenobiotic_induced | 0.81974568 |
| 158 | MP0001756_abnormal_urination | 0.81514858 |
| 159 | MP0001177_atelectasis | 0.81164486 |
| 160 | MP0004130_abnormal_muscle_cell | 0.81143833 |
| 161 | MP0002398_abnormal_bone_marrow | 0.81006350 |
| 162 | MP0003828_pulmonary_edema | 0.80877577 |
| 163 | MP0005448_abnormal_energy_balance | 0.79779559 |
| 164 | MP0003011_delayed_dark_adaptation | 0.79311562 |
| 165 | MP0001191_abnormal_skin_condition | 0.78096315 |
| 166 | MP0005253_abnormal_eye_physiology | 0.73323245 |
| 167 | MP0002098_abnormal_vibrissa_morphology | 0.71963736 |
| 168 | MP0006072_abnormal_retinal_apoptosis | 0.69831201 |
| 169 | MP0001664_abnormal_digestion | 0.68946445 |
| 170 | MP0004145_abnormal_muscle_electrophysio | 0.66612511 |
| 171 | MP0006276_abnormal_autonomic_nervous | 0.66260069 |
| 172 | MP0001340_abnormal_eyelid_morphology | 0.65688188 |
| 173 | MP0002152_abnormal_brain_morphology | 0.62349160 |
| 174 | MP0002102_abnormal_ear_morphology | 0.61831986 |
| 175 | MP0010771_integument_phenotype | 0.61562033 |
| 176 | MP0001348_abnormal_lacrimal_gland | 0.61141426 |
| 177 | MP0002184_abnormal_innervation | 0.59962357 |
| 178 | MP0009250_abnormal_appendicular_skeleto | 0.59525744 |
| 179 | MP0004185_abnormal_adipocyte_glucose | 0.58647270 |
| 180 | MP0003656_abnormal_erythrocyte_physiolo | 0.57290497 |
| 181 | MP0005388_respiratory_system_phenotype | 0.54779166 |
| 182 | MP0002133_abnormal_respiratory_system | 0.54779166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 8.15647231 |
| 2 | Petechiae (HP:0000967) | 8.06799028 |
| 3 | Increased mean platelet volume (HP:0011877) | 7.59830967 |
| 4 | Menorrhagia (HP:0000132) | 7.48271554 |
| 5 | Purpura (HP:0000979) | 7.00956294 |
| 6 | Abnormal platelet volume (HP:0011876) | 6.99106338 |
| 7 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.80618754 |
| 8 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.80618754 |
| 9 | Parakeratosis (HP:0001036) | 6.05108282 |
| 10 | Neurofibrillary tangles (HP:0002185) | 5.82722546 |
| 11 | Epistaxis (HP:0000421) | 5.50144175 |
| 12 | Gingival bleeding (HP:0000225) | 5.35436455 |
| 13 | Abnormality of the corticospinal tract (HP:0002492) | 5.01135751 |
| 14 | Sensory axonal neuropathy (HP:0003390) | 4.65524870 |
| 15 | Peripheral hypomyelination (HP:0007182) | 4.52389769 |
| 16 | Abnormal platelet function (HP:0011869) | 4.36603573 |
| 17 | Impaired platelet aggregation (HP:0003540) | 4.36603573 |
| 18 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.14716289 |
| 19 | Cerebral inclusion bodies (HP:0100314) | 4.01756444 |
| 20 | Acanthocytosis (HP:0001927) | 3.92955506 |
| 21 | Termporal pattern (HP:0011008) | 3.90486632 |
| 22 | Insidious onset (HP:0003587) | 3.90486632 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.88374561 |
| 24 | Onion bulb formation (HP:0003383) | 3.76315031 |
| 25 | Poikilocytosis (HP:0004447) | 3.45579809 |
| 26 | Cerebral hypomyelination (HP:0006808) | 3.38830227 |
| 27 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.37894393 |
| 28 | Spastic gait (HP:0002064) | 3.29573118 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 3.26347109 |
| 30 | Dyschromatopsia (HP:0007641) | 3.21180899 |
| 31 | Abnormality of glycolysis (HP:0004366) | 3.16078203 |
| 32 | Increased serum pyruvate (HP:0003542) | 3.16078203 |
| 33 | Stomatitis (HP:0010280) | 3.09131279 |
| 34 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.05762852 |
| 35 | Increased circulating renin level (HP:0000848) | 3.05707359 |
| 36 | Abnormal auditory evoked potentials (HP:0006958) | 3.03319019 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.98913173 |
| 38 | Hypomagnesemia (HP:0002917) | 2.98592224 |
| 39 | Retinal dysplasia (HP:0007973) | 2.95929370 |
| 40 | Metabolic alkalosis (HP:0200114) | 2.94290905 |
| 41 | Intention tremor (HP:0002080) | 2.89257432 |
| 42 | Joint swelling (HP:0001386) | 2.88511451 |
| 43 | Alacrima (HP:0000522) | 2.86564989 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.83928981 |
| 45 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79261680 |
| 46 | Autoimmune hemolytic anemia (HP:0001890) | 2.77652349 |
| 47 | Dysmetria (HP:0001310) | 2.74913011 |
| 48 | Leukodystrophy (HP:0002415) | 2.71712511 |
| 49 | Autoamputation (HP:0001218) | 2.70437076 |
| 50 | Nausea (HP:0002018) | 2.67971537 |
| 51 | Abnormality of nail color (HP:0100643) | 2.67866323 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.67627996 |
| 53 | Gangrene (HP:0100758) | 2.66520021 |
| 54 | Slow saccadic eye movements (HP:0000514) | 2.61855601 |
| 55 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.61556939 |
| 56 | Increased IgE level (HP:0003212) | 2.59822926 |
| 57 | Scanning speech (HP:0002168) | 2.58733037 |
| 58 | Hypokalemic alkalosis (HP:0001949) | 2.58150840 |
| 59 | Ankle clonus (HP:0011448) | 2.55942563 |
| 60 | Hypoplastic pelvis (HP:0008839) | 2.54641164 |
| 61 | Abnormality of iron homeostasis (HP:0011031) | 2.53767811 |
| 62 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.52342443 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.47920210 |
| 64 | Abnormal pupillary function (HP:0007686) | 2.46880235 |
| 65 | Absent septum pellucidum (HP:0001331) | 2.46816790 |
| 66 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.45985825 |
| 67 | Paralysis (HP:0003470) | 2.45349351 |
| 68 | Conjunctival telangiectasia (HP:0000524) | 2.44986630 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.43474199 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.43474199 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.43474199 |
| 72 | Bruising susceptibility (HP:0000978) | 2.43258751 |
| 73 | Premature skin wrinkling (HP:0100678) | 2.42227380 |
| 74 | Akinesia (HP:0002304) | 2.41776907 |
| 75 | Stridor (HP:0010307) | 2.41258670 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.39133257 |
| 77 | Spastic paraparesis (HP:0002313) | 2.38938928 |
| 78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37098301 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.37047432 |
| 80 | Increased serum ferritin (HP:0003281) | 2.35155315 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.31920286 |
| 82 | Thickened helices (HP:0000391) | 2.31910032 |
| 83 | Eczematoid dermatitis (HP:0000976) | 2.31352147 |
| 84 | Abnormality of magnesium homeostasis (HP:0004921) | 2.31168917 |
| 85 | Arterial thrombosis (HP:0004420) | 2.30706291 |
| 86 | Ventricular fibrillation (HP:0001663) | 2.29472992 |
| 87 | Cerebral hemorrhage (HP:0001342) | 2.28690238 |
| 88 | Anteriorly placed anus (HP:0001545) | 2.27620354 |
| 89 | Decreased central vision (HP:0007663) | 2.26854389 |
| 90 | Tinnitus (HP:0000360) | 2.24850172 |
| 91 | Decreased lacrimation (HP:0000633) | 2.24845126 |
| 92 | Renal Fanconi syndrome (HP:0001994) | 2.22688268 |
| 93 | Morphological abnormality of the inner ear (HP:0011390) | 2.21604954 |
| 94 | Clumsiness (HP:0002312) | 2.20175609 |
| 95 | Palmoplantar hyperkeratosis (HP:0000972) | 2.20102360 |
| 96 | Xanthomatosis (HP:0000991) | 2.19699970 |
| 97 | Pheochromocytoma (HP:0002666) | 2.19530408 |
| 98 | Cupped ear (HP:0000378) | 2.18716083 |
| 99 | Patchy hypopigmentation of hair (HP:0011365) | 2.18214717 |
| 100 | Retrobulbar optic neuritis (HP:0100654) | 2.17993240 |
| 101 | Optic neuritis (HP:0100653) | 2.17993240 |
| 102 | Erythroderma (HP:0001019) | 2.17752770 |
| 103 | Split foot (HP:0001839) | 2.17185969 |
| 104 | Erythema (HP:0010783) | 2.17132138 |
| 105 | Autoimmune thrombocytopenia (HP:0001973) | 2.15512382 |
| 106 | Ulnar claw (HP:0001178) | 2.15406758 |
| 107 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.14837041 |
| 108 | Adrenal hypoplasia (HP:0000835) | 2.13970212 |
| 109 | White forelock (HP:0002211) | 2.13890117 |
| 110 | Myokymia (HP:0002411) | 2.13507048 |
| 111 | Thick nail (HP:0001805) | 2.12797862 |
| 112 | Hepatosplenomegaly (HP:0001433) | 2.12243514 |
| 113 | CNS hypomyelination (HP:0003429) | 2.10594306 |
| 114 | Increased IgM level (HP:0003496) | 2.10308482 |
| 115 | Steppage gait (HP:0003376) | 2.10070759 |
| 116 | Methylmalonic acidemia (HP:0002912) | 2.09100672 |
| 117 | Abnormality of the septum pellucidum (HP:0007375) | 2.08468727 |
| 118 | Foot dorsiflexor weakness (HP:0009027) | 2.08467228 |
| 119 | Partial agenesis of the corpus callosum (HP:0001338) | 2.08307368 |
| 120 | Anomalous pulmonary venous return (HP:0010772) | 2.07973317 |
| 121 | Hypoplasia of the iris (HP:0007676) | 2.07299316 |
| 122 | Tongue fasciculations (HP:0001308) | 2.07291961 |
| 123 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.04977489 |
| 124 | Aplasia of the phalanges of the hand (HP:0009802) | 2.04977489 |
| 125 | Aplasia involving bones of the extremities (HP:0009825) | 2.04977489 |
| 126 | Esophageal atresia (HP:0002032) | 2.04217489 |
| 127 | Palmar hyperkeratosis (HP:0010765) | 1.99314876 |
| 128 | Coronal craniosynostosis (HP:0004440) | 1.97804060 |
| 129 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.95808422 |
| 130 | Decreased motor nerve conduction velocity (HP:0003431) | 1.94122434 |
| 131 | Neuroendocrine neoplasm (HP:0100634) | 1.91839087 |
| 132 | Orchitis (HP:0100796) | 1.91241968 |
| 133 | Pruritus (HP:0000989) | 1.91204623 |
| 134 | Plantar hyperkeratosis (HP:0007556) | 1.89730724 |
| 135 | Lower limb muscle weakness (HP:0007340) | 1.89461846 |
| 136 | Recurrent bacterial skin infections (HP:0005406) | 1.87883775 |
| 137 | Basal ganglia calcification (HP:0002135) | 1.87556089 |
| 138 | Myocardial infarction (HP:0001658) | 1.87313091 |
| 139 | Hypophosphatemic rickets (HP:0004912) | 1.87265466 |
| 140 | Abnormality of the foot musculature (HP:0001436) | 1.84297929 |
| 141 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.84282643 |
| 142 | Spastic tetraparesis (HP:0001285) | 1.83744435 |
| 143 | Prolonged neonatal jaundice (HP:0006579) | 1.83429843 |
| 144 | Curly hair (HP:0002212) | 1.82748671 |
| 145 | Synostosis involving the elbow (HP:0003938) | 1.82131190 |
| 146 | Humeroradial synostosis (HP:0003041) | 1.82131190 |
| 147 | Partial duplication of thumb phalanx (HP:0009944) | 1.81843426 |
| 148 | Vertigo (HP:0002321) | 1.81119450 |
| 149 | Episodic fever (HP:0001954) | 1.80919031 |
| 150 | Hammertoe (HP:0001765) | 1.80612915 |
| 151 | Papillary thyroid carcinoma (HP:0002895) | 1.80409366 |
| 152 | Keratoconjunctivitis sicca (HP:0001097) | 1.80372127 |
| 153 | Action tremor (HP:0002345) | 1.80044576 |
| 154 | Abnormality of the pulmonary veins (HP:0011718) | 1.79208677 |
| 155 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.77067169 |
| 156 | Hypoplasia of the fovea (HP:0007750) | 1.77067169 |
| 157 | Alopecia of scalp (HP:0002293) | 1.76771582 |
| 158 | Muscle fibrillation (HP:0010546) | 1.75546191 |
| 159 | Barrel-shaped chest (HP:0001552) | 1.74367007 |
| 160 | Axonal loss (HP:0003447) | 1.73911879 |
| 161 | Rickets (HP:0002748) | 1.73113581 |
| 162 | Vaginal atresia (HP:0000148) | 1.72158194 |
| 163 | Poor speech (HP:0002465) | 1.70528871 |
| 164 | Septo-optic dysplasia (HP:0100842) | 1.69204682 |
| 165 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.68903252 |
| 166 | Distal sensory impairment (HP:0002936) | 1.67926960 |
| 167 | 3-Methylglutaconic aciduria (HP:0003535) | 1.67779715 |
| 168 | Myelomeningocele (HP:0002475) | 1.67385221 |
| 169 | Urinary urgency (HP:0000012) | 1.67185699 |
| 170 | Abolished electroretinogram (ERG) (HP:0000550) | 1.66465824 |
| 171 | Acute necrotizing encephalopathy (HP:0006965) | 1.65802314 |
| 172 | Clonus (HP:0002169) | 1.65754552 |
| 173 | Increased density of long bones (HP:0006392) | 1.63554923 |
| 174 | Onycholysis (HP:0001806) | 1.63371932 |
| 175 | Keratoconjunctivitis (HP:0001096) | 1.62897776 |
| 176 | Abnormality of the fovea (HP:0000493) | 1.62541056 |
| 177 | Tetraparesis (HP:0002273) | 1.62150129 |
| 178 | Corneal erosion (HP:0200020) | 1.60800536 |
| 179 | Biliary tract neoplasm (HP:0100574) | 1.60232668 |
| 180 | Abnormality of secondary sexual hair (HP:0009888) | 1.59859357 |
| 181 | Abnormality of the axillary hair (HP:0100134) | 1.59859357 |
| 182 | Widely patent fontanelles and sutures (HP:0004492) | 1.59071827 |
| 183 | Encephalitis (HP:0002383) | 1.56532276 |
| 184 | Abnormality of proline metabolism (HP:0010907) | 1.56395920 |
| 185 | Hydroxyprolinuria (HP:0003080) | 1.56395920 |
| 186 | Upper limb muscle weakness (HP:0003484) | 1.54226039 |
| 187 | Congenital sensorineural hearing impairment (HP:0008527) | 1.53692696 |
| 188 | Abnormality of alanine metabolism (HP:0010916) | 1.53600522 |
| 189 | Hyperalaninemia (HP:0003348) | 1.53600522 |
| 190 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.53600522 |
| 191 | Hypergammaglobulinemia (HP:0010702) | 1.51700074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.77295166 |
| 2 | RIPK4 | 5.58661681 |
| 3 | OXSR1 | 4.75448131 |
| 4 | IRAK3 | 4.03557043 |
| 5 | EPHB1 | 3.89678739 |
| 6 | BMX | 3.10908905 |
| 7 | WNK4 | 3.10790222 |
| 8 | MAPKAPK5 | 2.88397612 |
| 9 | PBK | 2.85684469 |
| 10 | BCR | 2.85428471 |
| 11 | ACVR1B | 2.81603086 |
| 12 | PKN1 | 2.37207336 |
| 13 | EIF2AK1 | 2.32209314 |
| 14 | MYLK | 2.24324652 |
| 15 | MET | 2.18912987 |
| 16 | STK24 | 2.16969373 |
| 17 | TAOK3 | 2.16366450 |
| 18 | TNIK | 2.11524608 |
| 19 | WNK1 | 2.07724789 |
| 20 | CDK19 | 2.07577819 |
| 21 | STK3 | 2.03262759 |
| 22 | MST4 | 2.02669265 |
| 23 | FGFR2 | 1.98485086 |
| 24 | TEC | 1.92406458 |
| 25 | SIK3 | 1.82537153 |
| 26 | LIMK1 | 1.80812631 |
| 27 | IKBKB | 1.79724326 |
| 28 | BTK | 1.68674544 |
| 29 | UHMK1 | 1.67996855 |
| 30 | CSNK1G3 | 1.66226496 |
| 31 | MAP3K3 | 1.60515245 |
| 32 | CSNK1A1L | 1.57851106 |
| 33 | TAOK2 | 1.57432427 |
| 34 | MATK | 1.57264319 |
| 35 | SYK | 1.56403990 |
| 36 | PNCK | 1.52994254 |
| 37 | CASK | 1.51923833 |
| 38 | NEK6 | 1.50170286 |
| 39 | NTRK1 | 1.49635112 |
| 40 | ROCK2 | 1.37689496 |
| 41 | FGR | 1.36147683 |
| 42 | CLK1 | 1.35583332 |
| 43 | CAMK2B | 1.34440613 |
| 44 | MAP3K12 | 1.33894496 |
| 45 | CSF1R | 1.33353178 |
| 46 | CSNK1G1 | 1.33208297 |
| 47 | FER | 1.32111083 |
| 48 | SGK223 | 1.31312627 |
| 49 | SGK494 | 1.31312627 |
| 50 | TESK2 | 1.30675169 |
| 51 | MAP3K14 | 1.26620980 |
| 52 | ICK | 1.26249242 |
| 53 | GRK5 | 1.25439838 |
| 54 | IRAK4 | 1.23960184 |
| 55 | MAPKAPK3 | 1.23880890 |
| 56 | CSNK1G2 | 1.23340349 |
| 57 | EPHA2 | 1.22304263 |
| 58 | PTK2B | 1.19222277 |
| 59 | TAOK1 | 1.17992440 |
| 60 | CAMK2D | 1.14456434 |
| 61 | DAPK2 | 1.11640786 |
| 62 | DYRK2 | 1.04251656 |
| 63 | PIM2 | 1.00728896 |
| 64 | PRPF4B | 1.00315654 |
| 65 | TXK | 0.99957408 |
| 66 | MAPK15 | 0.99273130 |
| 67 | MAP3K11 | 0.98837034 |
| 68 | ZAP70 | 0.97064862 |
| 69 | PIK3CG | 0.96856348 |
| 70 | MAP3K5 | 0.91722467 |
| 71 | IKBKE | 0.90887260 |
| 72 | TYRO3 | 0.90824881 |
| 73 | TBK1 | 0.88432165 |
| 74 | CAMKK2 | 0.86601125 |
| 75 | CAMK2G | 0.86529085 |
| 76 | PAK6 | 0.86442401 |
| 77 | IRAK2 | 0.85054043 |
| 78 | PAK3 | 0.83736675 |
| 79 | ILK | 0.83002775 |
| 80 | BMPR1B | 0.82621998 |
| 81 | ERBB4 | 0.82582294 |
| 82 | MARK2 | 0.80816476 |
| 83 | PDK1 | 0.80094664 |
| 84 | HCK | 0.79747319 |
| 85 | RIPK1 | 0.79464685 |
| 86 | MUSK | 0.78569909 |
| 87 | PRKCQ | 0.78442614 |
| 88 | CAMK2A | 0.76801079 |
| 89 | EPHA4 | 0.76539351 |
| 90 | FRK | 0.76051861 |
| 91 | MAP3K1 | 0.75810395 |
| 92 | PRKCE | 0.75074565 |
| 93 | MARK3 | 0.73978451 |
| 94 | EPHA3 | 0.72465267 |
| 95 | MAP2K2 | 0.69958631 |
| 96 | PRKD1 | 0.67807987 |
| 97 | BLK | 0.67497921 |
| 98 | JAK1 | 0.67317160 |
| 99 | GRK6 | 0.67248179 |
| 100 | PLK2 | 0.66388129 |
| 101 | CDK5 | 0.66236650 |
| 102 | CDK14 | 0.66039641 |
| 103 | RPS6KA5 | 0.65613420 |
| 104 | AKT3 | 0.65564693 |
| 105 | LYN | 0.65337862 |
| 106 | MKNK1 | 0.63275279 |
| 107 | LMTK2 | 0.62777072 |
| 108 | TIE1 | 0.61260168 |
| 109 | IRAK1 | 0.60922233 |
| 110 | BRSK2 | 0.60834632 |
| 111 | DAPK3 | 0.60622167 |
| 112 | MARK1 | 0.60566169 |
| 113 | TRPM7 | 0.58575577 |
| 114 | TRIM28 | 0.56102140 |
| 115 | GRK1 | 0.54280966 |
| 116 | CHUK | 0.54234202 |
| 117 | ERBB2 | 0.52856951 |
| 118 | JAK3 | 0.51761503 |
| 119 | CDK15 | 0.51485269 |
| 120 | MAPK13 | 0.51157496 |
| 121 | PDPK1 | 0.50782032 |
| 122 | JAK2 | 0.50602364 |
| 123 | FYN | 0.50086445 |
| 124 | MAP2K3 | 0.49444754 |
| 125 | GRK7 | 0.49377807 |
| 126 | WNK3 | 0.48949649 |
| 127 | CDK18 | 0.47893890 |
| 128 | ADRBK2 | 0.47494830 |
| 129 | MAP2K1 | 0.47007642 |
| 130 | PDGFRB | 0.46934314 |
| 131 | SGK2 | 0.46930397 |
| 132 | CDK11A | 0.46275610 |
| 133 | CSNK1A1 | 0.45118484 |
| 134 | PRKG1 | 0.44660977 |
| 135 | YES1 | 0.43129456 |
| 136 | GSK3A | 0.42722317 |
| 137 | ADRBK1 | 0.41352072 |
| 138 | CSNK1D | 0.40969758 |
| 139 | PHKG2 | 0.40588746 |
| 140 | PHKG1 | 0.40588746 |
| 141 | PIK3CA | 0.40122666 |
| 142 | MAP3K9 | 0.38942078 |
| 143 | MAP3K2 | 0.37723703 |
| 144 | MAP2K6 | 0.36446621 |
| 145 | PRKACG | 0.35879867 |
| 146 | SGK3 | 0.34623742 |
| 147 | ARAF | 0.34316670 |
| 148 | PRKACB | 0.33863199 |
| 149 | KSR1 | 0.33241866 |
| 150 | FES | 0.32467728 |
| 151 | RET | 0.31819219 |
| 152 | CDC42BPA | 0.31611417 |
| 153 | PRKACA | 0.30154628 |
| 154 | PRKAA2 | 0.29310221 |
| 155 | INSR | 0.29154736 |
| 156 | TNK2 | 0.29126710 |
| 157 | TLK1 | 0.27631928 |
| 158 | SIK1 | 0.26792819 |
| 159 | STK11 | 0.25842089 |
| 160 | PAK1 | 0.25827360 |
| 161 | ITK | 0.25786218 |
| 162 | CSNK1E | 0.24659597 |
| 163 | CSK | 0.23807929 |
| 164 | HIPK2 | 0.23788811 |
| 165 | OBSCN | 0.23463360 |
| 166 | MELK | 0.23150744 |
| 167 | ROCK1 | 0.21787382 |
| 168 | DYRK1A | 0.21239902 |
| 169 | NME1 | 0.21016262 |
| 170 | CAMK1G | 0.20277167 |
| 171 | BMPR2 | 0.19342905 |
| 172 | DDR2 | 0.19317636 |
| 173 | MST1R | 0.17984811 |
| 174 | STK16 | 0.17922937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 6.02251334 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 5.35140151 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.91612845 |
| 4 | * Fatty acid elongation_Homo sapiens_hsa00062 | 3.62634895 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.51546624 |
| 6 | Platelet activation_Homo sapiens_hsa04611 | 3.42992282 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.95369733 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48031397 |
| 9 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.24863718 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.09278425 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.05840997 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.04795502 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.03495686 |
| 14 | Protein export_Homo sapiens_hsa03060 | 1.98183031 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.89277012 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88007457 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83817956 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.75551712 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75539562 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.70528017 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62664452 |
| 22 | Axon guidance_Homo sapiens_hsa04360 | 1.60340365 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.55805058 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.53792401 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.52668307 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50649436 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.49535861 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44793615 |
| 29 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.44520901 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.43694530 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.38493289 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.34896511 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.31252555 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31172465 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30608916 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.28593104 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25247325 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.20391830 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14700542 |
| 40 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.11661875 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11030563 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.09814471 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.09760217 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03736609 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03365867 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.02516381 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.02495733 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01782375 |
| 49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.01171324 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01068717 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.00837098 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00656913 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00121061 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99612066 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.99408198 |
| 56 | Tuberculosis_Homo sapiens_hsa05152 | 0.98727210 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96840009 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96237097 |
| 59 | Tight junction_Homo sapiens_hsa04530 | 0.93784298 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93549517 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92938835 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91354597 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90620691 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.89963843 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89679823 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.89294009 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88897943 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88488382 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.87733883 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85968909 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.85445650 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.85237164 |
| 73 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84156044 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.81471465 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.80633610 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78819852 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78809816 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78799877 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.78666357 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78103335 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76663936 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76573780 |
| 83 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.75183199 |
| 84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74117147 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72732123 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72281000 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71590540 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70103583 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70024802 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.68706054 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.68496689 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68469186 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66912781 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66273125 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.66203811 |
| 96 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.65558950 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.64103094 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62610067 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.62530602 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.62192277 |
| 101 | Phototransduction_Homo sapiens_hsa04744 | 0.61903565 |
| 102 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60968128 |
| 103 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60601163 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59417766 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58167246 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57665689 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57433675 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55776964 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55674037 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55567095 |
| 111 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54787091 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.54686118 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54557560 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54198532 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.53790532 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53341783 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53329084 |
| 118 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53323800 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50881609 |
| 120 | Measles_Homo sapiens_hsa05162 | 0.50077499 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49663190 |
| 122 | Bile secretion_Homo sapiens_hsa04976 | 0.49466683 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49254826 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48934336 |
| 125 | Salivary secretion_Homo sapiens_hsa04970 | 0.48797971 |
| 126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47746533 |
| 127 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47556528 |
| 128 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47264393 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47220543 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46743774 |
| 131 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46540147 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45848987 |
| 133 | Phagosome_Homo sapiens_hsa04145 | 0.45742165 |
| 134 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45474724 |
| 135 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45066326 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42098887 |
| 137 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.41871699 |
| 138 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41438569 |
| 139 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41438045 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40416192 |
| 141 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38969529 |
| 142 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38474931 |
| 143 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38223959 |
| 144 | Taste transduction_Homo sapiens_hsa04742 | 0.38152209 |
| 145 | Circadian entrainment_Homo sapiens_hsa04713 | 0.35147959 |
| 146 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34980876 |
| 147 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34396058 |
| 148 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31790995 |
| 149 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30509389 |
| 150 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27193419 |
| 151 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.26328468 |
| 152 | Renin secretion_Homo sapiens_hsa04924 | 0.25864158 |
| 153 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25655074 |
| 154 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.23878634 |
| 155 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.21267017 |
| 156 | ABC transporters_Homo sapiens_hsa02010 | 0.21048393 |
| 157 | Gap junction_Homo sapiens_hsa04540 | 0.20457854 |
| 158 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.20436394 |
| 159 | Nicotine addiction_Homo sapiens_hsa05033 | 0.19319220 |
| 160 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.18380798 |

